Budget Impact of Publicly Reimbursed Prescription Medicines in the Republic of Srpska

Frontiers in Public Health

Volumn 3, Issue , 2015, Pages

  Petrusic, Tamara ^a   Jakovljevic, Mihajlo ^b  

^a Inpharm Co doo   (Bosnia and Herzegovina)

^b University of Kragujevac Medical Faculty   (Serbia)

Author keywords

Bosnia; budget impact; cost; pharmaceuticals; prescription medicines; reimbursement; Republic of Srpska; trend

Indexed keywords

EID: 84962025683     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/fpubh.2015.00213     Document Type: Article

References (23)

1. Analysis of Population Health in Republic of Srpska. Banja Luka: Public Health Institute (2013).
2. Pharmacy Register (2015). Available from: www.vladars.net/Vlada/Ministarstva/MZSZ/PAO/Documents
3. Agency for Certification, Accreditation and Health Care Improvement of the Republic of Srpska (2015). Available from: www.askva.org/askva/bolnicki-sektor
4. Health Insurance Act (2015). Available from: http://www.vladars.net/Vlada/Ministarstva/Documents/Zakon o zdravstvenom osiguranju
5. National Health Insurance Fund (2015). Available from: www.zdravstvo-srpske.org
6. Ministry of Health and Social Welfare (2015). Available from: www.vladars.net/vlada/ministries/MHSW
7. Pension and Disability Insurance Fund (2015). Available from: www. fondpiors.org
8. WHO Global Health Observatory Data Repository. Bosnia and Herzegovina Statistics Summary. Available from: www.who.int/gho/data/node.country.country-BIH
9. BIH Agency for Statistics and Entity Statistical Offices. Preliminary Results of the 2013 Census of Population, Households and Dwelling in Bosnia and Herzegovina.
10. WHO Global Health Expenditure Database. Available from: www.who.int/health-accounts
11. Agency for Statistics of Bosnia and Herzegovina. National Health Accounts Statistics. Sarajevo: Agency for Statistics of Bosnia and Herzegovina (2014).
12. The Agency for Medicinal Products and Medical Devices of Bosnia and Herzegovina (2015). Available from: http://www.almbih.gov.ba/_doc/publikacije/Promet2013.pdf
13. WHO Collaborating Centre for Drug Statistic Methodology. ATC/DDD Index (2015). Available from: http://www.whocc.no/atc_ddd_index/
14. The Agency for Medicinal Products and Medical Devices of Bosnia and Herzegovina (2014). Available from: www.almbih.gov.ba/_doc/publikacije/Promet2013.pdf
15. Republic of Srpska Public Health Institute. Available from: www.phi.rs.ba
16. Agency for Statistics of Bosnia and Herzegovina. Available from: www.bhas.ba
17. Jakovljevic MB. Oncology monoclonal antibodies expenditure trends and reimbursement projections in the emerging Balkan market. Farmeconomia. Health Econ Ther Pathways (2014) 15(1):27–32.10.7175/fe.v15i1.909
18. Jakovljevic MB. Resource allocation strategies in Southeastern European health policy. Eur J Health Econ (2013) 14(2):153–9.10.1007/s10198-012-0439-y23143312
19. Jakovljevic M Djordjevic N Jurisevic M Jankovic S. Evolution of Serbian pharmaceutical market alongside socioeconomic transition. Expert Rev Pharmacoecon Outcomes Res (2015) 15(3):521–30.10.1586/14737167.2015.100304425592856
20. Jakovljevic MB. Health expenditure dynamics in Serbia 1995-2012, hospital pharmacology. Int Multidiscip J (2014) 1(3):180–3.
21. Dagovic A Zugic A Jakovljevic MB. Macroeconomic policy impact on oncology-related public expenditure in an emerging European market – signs of early recovery. Ser J Exp Clin Res (2015) 16(1):43–50.
22. Jakovljevic M Jovanovic M Lesch MO. Accessibility and affordability of alcohol dependency medical care in Serbia. Front Psychiatry (2015) 5:192.10.3389/fpsyt.2014.00192
23. Jakovljevic M Vukovic M Chia-Ching C Antunovic M Dragojevic-Simic V Velickovic-Radovanovic R et al. Do health reforms impact cost consciousness of health care professionals? Results from a nation-wide survey in the Balkans. Balkan Med J (2015).10.5152/balkanmedj.2015.15869